Palo Alto, CA (PRWEB) April 25, 2013
Centrillion Biosciences, a leading genomic and bioinformatics solution provider, has announced a new grant program focused on innovation in the application of next-gen sequencing technology. The Sequencing Innovation Grant award is open to academic, clinical and industrial researchers. The Grant will be awarded to research proposals demonstrating innovative applications of next generation sequencing technology.
Grants will be awarded in the form of sample sequencing and bioinformatics analysis services for moderate sized projects. Projects involving whole genomes, exomes, targeted and transcriptome sequencing are eligible.
While the grant is open to all researchers, the initial focus will be on encouraging investigators who are new to next generation sequencing technology to embark on pilot projects that have the greatest potential to lead to significant research programs. The study areas are open but proposals to further findings that may lead to potential clinical applications of sequencing results are especially encouraged.
“Centrillion is a leader in deploying genomics research services to academic and clinical researchers”, said Wei Zhou, CEO of Centrillion, “With this program, we hope to encourage more researchers to apply advanced genomic technologies to advance their research goals.”
Proposals will be reviewed by a Centrillion-appointed committee consisting of Ph.D. level scientists with significant next generation sequencing and genomics technical application experience.
The program is open to all researchers in the USA. The submission deadline is May 17, 2013. Full details may be found on the Centrillion web site: http://www.centrillionbio.com
About Centrillion Biosciences Inc.
Centrillion Biosciences is a leading genomic and bioinformatics solution provider. Our genomic technology dramatically improves sequencing performance and is compatible with leading genomic technology platforms. With the highest customer return and referral rate, our genomic and bioinformatics services utilize leading technologies and beyond to deliver the highest quality data in the fastest sample to result time. Our world class genomic technology development expertise enables our customers to succeed in the most challenging genomic research projects.
Robert Feldman, Ph.D.
Vice President of Business Development
Centrillion Biosciences, Inc.
2438 Embarcadero Way
Palo Alto, CA 94303
Read the full story at http://www.prweb.com/releases/2013/4/prweb10668083.htm.
Copyright©2012 Vocus, Inc.
All rights reserved